A B S T R A C T To determine the effect of elevations of plasma lipids on growth hormone secretion in humans, paired insulin hypoglycemia tests and paired arginine infusion tests were performed on eight and six normal female volunteers respectively. On 1 of the 2 test days for each growth hormone stimulus, subjects were given 60 g corn oil (Lipomul) 3 hr before testing followed by intravenous heparin (5000 U) at the time of insulin or arginine administration.
A B S T R A C T To determine the effect of elevations of plasma lipids on growth hormone secretion in humans, paired insulin hypoglycemia tests and paired arginine infusion tests were performed on eight and six normal female volunteers respectively. On 1 of the 2 test days for each growth hormone stimulus, subjects were given 60 g corn oil (Lipomul) 3 hr before testing followed by intravenous heparin (5000 U) at the time of insulin or arginine administration.
Lipomul plus heparin administration inhibited both insulin-and arginine-induced plasma HGH elevations with almost complete suppression of the response to arginine. The plasma HGH (human growth hormone) inhibition was associated with elevation in plasma triglycerides and inhibition of plasma FFA (free fatty acid) depression after insulin or arginine. Neither the hypoglycemic response to insulin nor the blood glucose and plasma immunoreactive-insulin responses to arginine were altered by Lipomul plus heparin administration.
In four additional subjects in whom Lipomul was given without heparin, the elevated plasma triglyceride values were not associated with suppression of arginineinduced plasma HGH elevations. In the same four subjects, heparin administration without Lipomul neither suppressed arginine-induced plasma HGH elevations nor prevented the depression in plasma FFA after arginine as much as when Lipomul plus heparin had been given. These latter observations suggest that the elevation in plasma FFA was responsible for suppression of growth hormone secretion by Lipomul plus heparin. These studies indicate a possible role of plasma FFA in regulation of growth hormone secretion. (1) . Two of these metabolites (glucose and amino acids) have been shown to influence growth hormone secretion in humans (2, 3) . In a previous report from this laboratory, an inhibitory effect of lipid infusions on insulin-induced growth hormone elevations in Rhesus monkeys was shown (4 FIGURE 1 Effect of oral Lipomul and intravenously administered heparin on insulin-induced plasma HGH elevations in humans. The subjects ingested 90 ml Lipomul 3 hr before the first blood sample and intravenous heparin (5000 U) was administered at zero time. Means +SEM are shown.
INTRODUCTION
tests, regular insulin (0.1 U/kg) was given intravenously and in the arginine tests, 30 g L-arginine monohydrochloride as a 10% solution was infused over 30 min. On the days of Lipomul ingestion, heparin (5000 U) was given intravenously at the time of administration of arginine or insulin. Blood samples were collected in chilled heparinized tubes every 15 min during the 15 min baseline period and for 90 min after the insulin had been given or the arginine infusion had been started. Protein free filtrates for blood glucose were made from 0.2 ml blood, and blood glucose was determined by a glucose oxidase method (6) . After a portion had been taken for blood glucose determination, the blood was centrifuged and 1 ml plasma was immediately placed in the Dole FFA ex-. with buffer. L-arginine monohydrochloride as a 10% solution was purchased from Cutter Laboratories, Inc., Berkeley, Calif. Lipomul was purchased from The Upjohn Company, Kalamazoo, Mich. Sodium heparin (Liquaemin Sodium "100") was purchased from Organon Inc., West Orange, N. J. Fig. 1 shows the effect of treatment with Lipomul plus heparin on insulin-induced plasma HGH elevations in eight normal female volunteers. Plasma HGH rose significantly less during the insulin tests in which the subjects were given Lipomul plus heparin than in the control test in which insulin alone was given (P < 0.02 at 45, 60, 75, and 90 min). Administration of Lipomul plus heparin to the subjects also resulted in increased plasma triglyceride concentrations without any significant change in the hypoglycemic response to insulin (Fig. 2) . Plasma FFA were elevated when Lipomul plus heparin had been given and did not fall after insulin injection to the extent seen when insulin was given alone.
RESULTS
Lipomul plus heparin administration also inhibited the arginine-induced plasma HGH elevations in six normal female volunteers (Fig. 3) . Plasma HGH concentrations were significantly less at 45, 60, 75, and 90 min when Lipomul plus heparin were given than in the control experiments (P < 0.01 at each interval). After the administration of Lipomul plus heparin, plasma triglycerides were increased by approximately 50% (Fig. 4) . Plasma FFA concentrations were also increased and did not fall after arginine infusion to the degree seen in the control experiments with arginine alone. The alterations in plasma lipids caused by oral Lipomul and intravenous heparine administration did not significantly alter the blood glucose or plasma IRI response to arginine (Fig.  5 ). Paired arginine-infusion studies were performed on four additional subjects. The subjects received Lipomul alone before one of the infusions and heparin alone with the other. The plasma HGH responses to arginine were similar during both tests (Fig. 6 ) and did not appear inhibited compared to the response when arginine alone was administered to other subjects (Fig. 3) . Plasma triglycerides were elevated by Lipomul but the plasma FFA and blood glucose responses to arginine were similar when either Lipomul alone or heparin alone was given (Fig. 6) (4) . In addition, the unmasking of a stimulatory effect of epinephrine on growth hormone secretion by simultaneous administration of the beta adrenergic blocker propranolol suggests that either plasma FFA elevation or opposing beta receptor stimulation is responsible for the failure of epinephrine alone to increase plasma HGH (11) . Also, Irie, Sakuma, Tsushima, Shizume, and Nakao have suggested that plasma HGH elevations occurring after nicotinic acid administration were related to a fall in plasma FFA since both the plasma FFA depression and HGH elevation could be inhibited by heparin (12) . Direct proof that the suppressive effect of lipids on growth hormone secretion in humans is due to FFA rather than to some other factor, will depend on studies performed when satisfactory means of physiologically administering free fatty acids to humans is available.
The delicate interrelationships between the various metabolites regulating growth hormone secretion make it difficult to determine which of the factors are most significant in the fine control of growth hormone secretion. For example, the plasma HGH response to insulin could theoretically be due to a depression in FFA as well as to hypoglycemia. The observation that the plasma HGH response to insulin can be prevented by administering intravenous glucose (13) could be interpreted as indicating that hypoglycemia is more responsible for stimulating growth hormone secretion. However, the present investigations showing inhibition of insulin-induced growth hormone elevations by lipids suggest that depression in plasma FFA might also be an important stimulus for growth hormone secretion after insulin administration. The almost complete inhibition of arginine-induced plasma HGH elevations by modest alterations in plasma lipids when Lipomul plus heparin are given, justifies speculation as to whether arginine stimulates growth hormone secretion directly or, in part, by its effect on FFA. As arginine causes hyperglycemia, changes in blood glucose concentration certainly are not responsible for arginine-induced plasma HGH elevations.
An inhibitory effect of FFA on growth hormone secretion might have been anticipated from information available on insulin and growth hormone homeostasis. With the exception of amino acids, which stimulate both insulin and growth hormone secretion, many of the regulatory factors for insulin secretion also affect growth hormone secretion but in reciprocal fashion. Hyperglycemia and hypoglycemia have opposite effects on insulin and growth hormone secretion. The adrenergic control mechanisms demonstrated for insulin and growth hormone secretion are also reciprocal (14) . Alpha adrenergic receptor stimulation inhibits insulin secretion but enhances growth hormone secretion whereas beta receptor stimulation increases insulin secretion but inhibits growth hormone secretion. Although direct evidence for an effect of FFA on insulin secretion in man is lacking, FFA have been shown to stimulate insulin secretion in the dog (15) . The inhibitory effect of FFA on growth hormone secretion suggested in this report further corroborates the reciprocal relationship between insulin and growth hormone.
